- Home
- MNSB vs TARA Comparison
MNSB vs TARA Comparison
Compare MNSB & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- TARA
- Stock Information
- Founded
- MNSB 2003
- TARA N/A
- Country
- MNSB United States
- TARA United States
- Employees
- MNSB N/A
- TARA N/A
- Industry
- MNSB Major Banks
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNSB Finance
- TARA Health Care
- Exchange
- MNSB Nasdaq
- TARA Nasdaq
- Market Cap
- MNSB 140.1M
- TARA 165.5M
- IPO Year
- MNSB N/A
- TARA N/A
- Fundamental
- Price
- MNSB $19.10
- TARA $7.42
- Analyst Decision
- MNSB
- TARA Strong Buy
- Analyst Count
- MNSB 0
- TARA 7
- Target Price
- MNSB N/A
- TARA $20.33
- AVG Volume (30 Days)
- MNSB 38.2K
- TARA 626.4K
- Earning Date
- MNSB 10-27-2025
- TARA 11-10-2025
- Dividend Yield
- MNSB 2.11%
- TARA N/A
- EPS Growth
- MNSB N/A
- TARA N/A
- EPS
- MNSB N/A
- TARA N/A
- Revenue
- MNSB $69,367,000.00
- TARA N/A
- Revenue This Year
- MNSB $23.19
- TARA N/A
- Revenue Next Year
- MNSB $2.92
- TARA N/A
- P/E Ratio
- MNSB N/A
- TARA N/A
- Revenue Growth
- MNSB 9.71
- TARA N/A
- 52 Week Low
- MNSB $15.00
- TARA $2.36
- 52 Week High
- MNSB $22.98
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- MNSB 51.34
- TARA 76.46
- Support Level
- MNSB $18.15
- TARA $5.00
- Resistance Level
- MNSB $19.54
- TARA $6.85
- Average True Range (ATR)
- MNSB 0.46
- TARA 0.56
- MACD
- MNSB 0.12
- TARA 0.23
- Stochastic Oscillator
- MNSB 57.36
- TARA 87.60
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).